DF/HCC New Member

Please welcome Dr. McNamee who recently joined DF/HCC and is a member of Cancer Genetics and Lung Cancer Programs.

Transcript:
Hi, my name is Ciaran McNamee. I am one of the thoracic surgeons working in the Dana-Farber Cancer Institute and Brigham and Women’s Hospital [and DF/HCC] in the Lung Cancer, [and Cancer] Genetics [Programs].

I work in dealing with the surgical aspect of lung cancer care. My primary research focus is on carcinoid tumors. I am interested in these tumors because they occur occasionally in a multicentric form and these are a unique group of tumors they are predominantly 95 percent in female-dominant and I believe that there may be a cancer progression with these tumors leading from the earliest stage which is Diffuse Idiopathic Pulmonary Neuroendocrine Hyperplasia (DIPNECH). With the acronym leading to carcinoid tumorlets, leading to carcinoid tumors both atypical and typical. And a unique quality about this is patients serve as their own controls because they have normal cells, DIPNECH cells, carcinoid tumorlet cells and carcinoid tumors, and so, they are a great group of patients to be able to see for mutation analysis for development of cancer in development of lung cancer.